SCHEMBL106258

SCHEMBL106258

c1ccc([PH](CCC[PH](c2ccccc2)(c2ccccc2)c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
GLA P06280 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
CA9 Q16790 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CA14 Q9ULX7 1/20 0.33
KCNA3 P22001 1/20 0.32
CALM1 P0DP23 1/20 0.32
ALDH1A1 P00352 2/20 0.31
MAPT P10636 1/20 0.31
IDO1 P14902 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5232942 0.97 TSHR (0.38) TSHRCA12CA1CA2GLA
Bromide SCHEMBL30490539 0.97 TSHR (0.38) TSHRCA12CA1CA2GLA
SCHEMBL838143 0.94 TSHR (0.39) TSHRCA12CA1CA2GLA
SCHEMBL837455 0.92 TSHR (0.38) TSHRCA12CA1CA2GLA
SCHEMBL6767743 0.92 TSHR (0.38) TSHRCA12CA1CA2GLA
SCHEMBL12787151 0.92 TSHR (0.38) TSHRCA12CA1CA2GLA
SCHEMBL837395 0.92 TSHR (0.38) TSHRCA12CA1CA2GLA
SCHEMBL837701 0.92 TSHR (0.38) TSHRCA12CA1CA2GLA
SCHEMBL12787153 0.92 TSHR (0.38) TSHRCA12CA1CA2GLA
SCHEMBL11897049 0.92 TSHR (0.38) TSHRCA12CA1CA2GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6730812-B2 BALL-MILLING AND SALT FORMATION, CATALYTIC REACTION IN ONE POT; CATALYST SELECTIVITY, EFFICIENCY, LOW TEMPERATURE, SIMPLIFICATION; FORMING UNSATURATED COMPOUNDS, 4-BROMOSTYRENE, ISOPROPENYLNAPHTHALENE/1-/ IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2004-05-04 US claimed
CN-116621877-B Thioether-containing biphosphinyl cationic liquid, preparation method thereof and extraction method for heavy metals in aqueous solution 天津大学 2025-06-17 CN disclosed
CN-116621877-A Thioether-containing biphosphinyl cationic liquid, preparation method thereof and extraction method for heavy metals in aqueous solution 天津大学 2023-08-22 CN disclosed
EP-3653613-B1 1,3-DI-SUBSTITUTED KETENE COMPOUND AND APPLICATION THEREOF BEBETTER MED INC (CN) 2022-11-16 EP disclosed
US-11306102-B2 1,3-di-substituted ketene compound and application thereof BEBETTER MED INC. (CN) 2022-04-19 US disclosed
US-20210122761-A1 1,3-DI-SUBSTITUTED KETENE COMPOUND AND APPLICATION THEREOF BEBETTER MED INC. (CN) 2021-04-29 US disclosed
EP-3653613-A1 1,3-DI-SUBSTITUTED KETENE COMPOUND AND APPLICATION THEREOF Guangzhou Bebetter Medicine Technology Co., Ltd. (CN) 2020-05-20 EP disclosed
EP-2940008-B1 NOVEL BENZAZEPINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF SANWA KAGAKU KENKYUSHO CO (JP) 2017-05-17 EP disclosed
US-9586905-B2 Benzoazepine derivative and medical use thereof SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 2017-03-07 US disclosed
EP-2940008-A1 NOVEL BENZAZEPINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF Sanwa Kagaku Kenkyusho Co., Ltd (JP) 2015-11-04 EP disclosed
US-20070286059-A1 Optical Information Recording Medium and Optical Information Recording Method FUJIFILM CORPORATION (JP) 2007-12-13 US disclosed
US-20070214987-A1 Lithographic printing plate precursor FUJIFILM CORPORATION 2007-09-20 US disclosed
US-20070082290-A1 Planographic printing plate precursor FUJI PHOTO FILM CO., LTD. (JP) 2007-04-12 US disclosed
US-20070042293-A1 Including an aromatic diphosphonium compound along with an addition polymerization promoter, unsaturated compound, protective layeron an sluminium support; laser recording having excellent ink receptibility during printing and printing durability; strength; on-press development; image strength FUJI PHOTO FILM CO., LTD. 2007-02-22 US disclosed
US-20020077250-A1 Process for preparing aryl compounds BAYER AKTIENGESELLSCHAFT (DE) 2002-06-20 US disclosed
EP-1003731-A1 PROCESS FOR THE MANUFACTURE OF EPOXY COMPOUNDS SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 2000-05-31 EP disclosed
WO-1999009020-A1 PROCESS FOR THE MANUFACTURE OF EPOXY COMPOUNDS SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 1999-02-25 WO disclosed
EP-0433836-B1 Halophenyl substituted dioxanes HOFFMANN LA ROCHE (CH) 1996-03-27 EP disclosed
US-5322638-A Halophenyl substituted dioxanes HOFFMANN-LA ROCHE INC. (US) 1994-06-21 US disclosed
EP-0433836-A2 Halophenyl substituted dioxanes F. HOFFMANN-LA ROCHE AG (CH) 1991-06-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020077250-A1 Process for preparing aryl compounds TYR, ABL1, AHR TSHR 2570/4885CA12 2362/4885CA1 4056/4885
US-20210122761-A1 1,3-DI-SUBSTITUTED KETENE COMPOUND AND APPLICATION THEREOF PPARA, FABP1, PPARG TSHR 2220/4885CA12 4825/4885CA1 4752/4885
US-11306102-B2 1,3-di-substituted ketene compound and application thereof PPARA, FABP1, PPARG TSHR 2220/4885CA12 4825/4885CA1 4752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.